Skip to content

Dia Fibrin

by Diatech, Inc. United States 510(k)

510(k) K841366

Product code KQJ

Overview

Dia Fibrin is a System, Fibrinogen Determination device used for measuring fibrinogen levels in blood samples. Fibrinogen is a key protein involved in blood clotting, and its accurate quantification is essential for diagnosing and managing coagulation disorders, such as hemophilia or disseminated intravascular coagulation (DIC). This device falls under the Hematology specialty and is classified as a Class 2 medical device, indicating moderate regulatory oversight due to its clinical relevance.

The Dia Fibrin system is intended for in vitro diagnostic use in clinical laboratories. It operates as a single-use reagent kit, requiring no sterilization beyond manufacturer-provided packaging. The device is not designed for MRI environments and must be stored under controlled conditions as specified by the manufacturer. Authorized under FDA 510K clearance (K841366), it adheres to regulatory standards outlined in 21 CFR 864.7340, ensuring compliance with hematology diagnostic requirements.

Summary written by AI from registry data, 1 Oct 2026.Not verified

About this summary

This description and any FAQs on this page were generated automatically and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK841366 Date1 Jun 1984ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Not covered

United States — FDA 510(k) Active

Recalls: none on record (FDA, checked 5 Oct 2026)

Specification

510(k) · synced 5 Oct 2026

510(k) Number
FDA Product Code
KQJ
Device Class
Class II
Regulation
21 CFR Part 864.7340
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Other devices from Diatech, Inc.

See all devices from Diatech, Inc. →

Questions

  • What is the Dia Fibrin system used for?

    The Dia Fibrin system is designed for in vitro diagnostic use to measure fibrinogen levels in blood samples. Fibrinogen is a critical protein in blood clotting, and accurate measurement helps diagnose and manage coagulation disorders such as hemophilia or disseminated intravascular coagulation (DIC). It is specifically intended for clinical laboratory settings to support hematological assessments.

  • How is the Dia Fibrin system supplied, and is it reusable?

    The Dia Fibrin system is supplied as a single-use reagent kit. Each kit is pre-packaged and does not require additional sterilization beyond the manufacturer’s provided packaging. This ensures consistency and safety for each use, eliminating the need for reprocessing or reuse.

  • Does the Dia Fibrin system require special storage conditions?

    Yes, the Dia Fibrin system must be stored under controlled conditions as specified by the manufacturer. Proper storage ensures the stability and accuracy of the reagent kit, which is essential for reliable fibrinogen measurements in clinical diagnostics.

  • Can the Dia Fibrin system be used in an MRI environment?

    No, the Dia Fibrin system is not designed for use in MRI environments. The device is intended solely for in vitro diagnostic use in clinical laboratories, where it operates independently of magnetic fields or imaging equipment.

  • What regulatory clearance does the Dia Fibrin system hold?

    The Dia Fibrin system holds FDA 510K clearance under the reference number K841366. This clearance indicates that the device has been deemed substantially equivalent to a legally marketed predicate device and complies with regulatory standards outlined in 21 CFR 864.7340 for hematology diagnostic devices.

Properties & raw data

Show properties, registry sources and raw records

Sources (1)

  • FDA 510(k) K841366 24 fields · synced 5 Oct 2026